共 50 条
Assessment of the association between glycemic variability and diabetes-related complications in type 1 and type 2 diabetes
被引:166
|作者:
Smith-Palmer, J.
[1
]
Braendle, M.
[2
]
Trevisan, R.
[3
]
Federici, M. Orsini
[4
]
Liabat, S.
[5
]
Valentine, W.
[1
]
机构:
[1] Ossian Hlth Econ & Commun, CH-4051 Basel, Switzerland
[2] Kantonsspital St Gallen, St Gallen, Switzerland
[3] Osped Riuniti Bergamo, I-24100 Bergamo, Italy
[4] SpA, Medtron Italia, Milan, Italy
[5] Medtron Int Trading Sarl, Tolochenaz, Switzerland
关键词:
Glycemic variability;
Microvascular complications;
Macrovascular complications;
FASTING PLASMA-GLUCOSE;
CORONARY-ARTERY-DISEASE;
MEAN BLOOD-GLUCOSE;
HBA(1C) VARIABILITY;
MICROVASCULAR COMPLICATIONS;
CARDIOVASCULAR-DISEASE;
RISK-FACTOR;
INDEPENDENT CORRELATE;
CHRONIC HYPERGLYCEMIA;
RENAL-INSUFFICIENCY;
D O I:
10.1016/j.diabres.2014.06.007
中图分类号:
R5 [内科学];
学科分类号:
1002 ;
100201 ;
摘要:
Chronic hyperglycemia is the main risk factor for the development of diabetes-related complications in both type 1 and type 2 diabetes, but it is thought that frequent or large glucose fluctuations may contribute independently to diabetes-related complications. A systematic literature review was performed using the PubMed, EMBASE and Cochrane Library databases with searches limited to studies published from June 2002 to March 2014, in English and including >= 50 patients. Twenty eight articles were included in the final review. Eighteen studies reported the association between glucose variability and diabetes-related complications exclusively in type 2 diabetes. A positive association between increased variability and microvascular complications and coronary artery disease was consistently reported. Associations between glucose variability and other macrovascular complications were inconsistent in type 2 diabetes. Seven studies examined the association between glucose variability and complications exclusively in type 1 diabetes. Increased glucose variability appears to play a minimal role in the development of micro- and macrovascular complications in type 1 diabetes. Consistent findings suggest that in type 2 diabetes glucose variability is associated with development of microvascular complications. The role of increased glucose variability in terms of microvascular and macrovascular complications in type 1 diabetes is less clear; more data in are needed. (C) 2014 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:273 / 284
页数:12
相关论文